Company Filing History:

5 out of 112

Asta Medica, Aktiengesellschaft

patents

2 out of 36

Aeterna Zentaris Gmbh

Years Active: 1996-2010

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7718599 - Pharmaceutical administration form for peptides, process for its preparation, and use (2010-05-18),

2. 7696149 - Pharmaceutical administration form for peptides, process for its preparation, and use (2010-04-13),

3. 7214662 - Injectable solution of an LHRH antagonist (2007-05-08),

4. 6544551 - Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis (2003-04-08),

5. 6348490 - Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability (2002-02-19),

6. 6322812 - Pharmaceutical forms for the oral administration of mesna (2001-11-27),

7. 6284287 - Particulate formulation for administration by inhalation (2001-09-04),

8. 5990152 - Dosage forms containing thioctic acid or solid salts of thioctic acid (1999-11-23),

9. 5527539 - Tablets with thioctic acid of specific particle size (1996-06-18),

Title: **Werner Sarlikiotis: An Innovator in Pharmaceutical Patents**

Introduction

Werner Sarlikiotis is a notable inventor based in Frankfurt-am-Main, Germany, recognized for his contributions to the pharmaceutical field through his innovative patents. With a total of nine patents to his name, Sarlikiotis has made significant strides in the development of pharmaceutical formulations, particularly those involving peptides.

Latest Patents

Sarlikiotis's latest patents focus on creating effective pharmaceutical compositions for peptide administration. One of his key inventions describes a pharmaceutical administration form for peptides, which consists of various salts like acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate, or phosphate salts, either in dissolved or dispersed form. This invention emphasizes the importance of combining these salts with free acid forms to optimize the pharmaceutical effectiveness. Additionally, he has developed a method for preventing aggregation of LHRH antagonists in pharmaceutical compositions, ensuring the efficacy and stability of these critical compounds.

Career Highlights

Throughout his career, Werner Sarlikiotis has held positions at esteemed companies such as Asta Medica and Aeterna Zentaris GmbH. His work in these organizations has been instrumental in advancing research and development in pharmaceutical sciences, particularly in formulations that enhance drug delivery and bioavailability.

Collaborations

Sarlikiotis's journey in innovation has also seen him collaborate with notable colleagues, including Horst Bauer and Matthias Rischer. These partnerships have played a vital role in nurturing ideas and contributing to the successful realization of multiple patent applications.

Conclusion

Werner Sarlikiotis continues to be a prominent figure in the realm of pharmaceutical inventions. His dedication to improving peptide formulations and his innovative approaches to drug stability position him as a valuable contributor to the industry. As he unfolds future advancements, his existing patents will undoubtedly have a lasting impact on pharmaceutical practices.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.